NEW YORK AND LONDON
Celsus Therapeutics (OTCQB: CLSXY), an emerging growth, development-stage biopharmaceutical company, announces the appointment of Pablo Jimenez, M.D., to the position of Chief Medical Officer.
A Revolution in Treating Autoinflammatory & Orphan Diseases